• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Wellcome Open Res . Effective immunity and second waves: a dynamic causal modelling study

tetano

Editor, Senior Moderator
Wellcome Open Res


. 2020 Sep 30;5:204.
doi: 10.12688/wellcomeopenres.16253.2. eCollection 2020.
Effective immunity and second waves: a dynamic causal modelling study


Karl J Friston[SUP] 1 [/SUP], Thomas Parr[SUP] 1 [/SUP], Peter Zeidman[SUP] 1 [/SUP], Adeel Razi[SUP] 1 2 [/SUP], Guillaume Flandin[SUP] 1 [/SUP], Jean Daunizeau[SUP] 3 [/SUP], Oliver J Hulme[SUP] 4 5 [/SUP], Alexander J Billig[SUP] 6 [/SUP], Vladimir Litvak[SUP] 1 [/SUP], Cathy J Price[SUP] 1 [/SUP], Rosalyn J Moran[SUP] 7 [/SUP], Anthony Costello[SUP] 8 [/SUP], Deenan Pillay[SUP] 9 [/SUP], Christian Lambert[SUP] 1 [/SUP]



Affiliations
Free PMC article

Abstract

This technical report addresses a pressing issue in the trajectory of the coronavirus outbreak; namely, the rate at which effective immunity is lost following the first wave of the pandemic. This is a crucial epidemiological parameter that speaks to both the consequences of relaxing lockdown and the propensity for a second wave of infections. Using a dynamic causal model of reported cases and deaths from multiple countries, we evaluated the evidence models of progressively longer periods of immunity. The results speak to an effective population immunity of about three months that, under the model, defers any second wave for approximately six months in most countries. This may have implications for the window of opportunity for tracking and tracing, as well as for developing vaccination programmes, and other therapeutic interventions.

Keywords: Bayesian; compartmental models; coronavirus; dynamic causal modelling; epidemiology; variational.
 
Back
Top Bottom